123 related articles for article (PubMed ID: 34664962)
1. Chemical Components of the Fruits of
Wang Y; Zheng M; Jiang Q; Xu Y; Zhou X; Zhang N; Sun D; Li H; Chen L
J Agric Food Chem; 2021 Oct; 69(42):12433-12444. PubMed ID: 34664962
[TBL] [Abstract][Full Text] [Related]
2. Azacoccone E inhibits cancer cell growth by targeting 3-phosphoglycerate dehydrogenase.
Guo J; Gu X; Zheng M; Zhang Y; Chen L; Li H
Bioorg Chem; 2019 Jun; 87():16-22. PubMed ID: 30852233
[TBL] [Abstract][Full Text] [Related]
3. Ixocarpalactone A from dietary tomatillo inhibits pancreatic cancer growth by targeting PHGDH.
Zheng M; Guo J; Xu J; Yang K; Tang R; Gu X; Li H; Chen L
Food Funct; 2019 Jun; 10(6):3386-3395. PubMed ID: 31112178
[TBL] [Abstract][Full Text] [Related]
4. Identification of Novel Natural Inhibitors to Human 3-Phosphoglycerate Dehydrogenase (PHGDH) for Cancer Treatment.
Sadiqa A; Rasul A; Hassan M; Sultana S; Jabeen F
Molecules; 2022 Sep; 27(18):. PubMed ID: 36144843
[TBL] [Abstract][Full Text] [Related]
5. Identification of a small molecule inhibitor of 3-phosphoglycerate dehydrogenase to target serine biosynthesis in cancers.
Mullarky E; Lucki NC; Beheshti Zavareh R; Anglin JL; Gomes AP; Nicolay BN; Wong JC; Christen S; Takahashi H; Singh PK; Blenis J; Warren JD; Fendt SM; Asara JM; DeNicola GM; Lyssiotis CA; Lairson LL; Cantley LC
Proc Natl Acad Sci U S A; 2016 Feb; 113(7):1778-83. PubMed ID: 26831078
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of 3-phosphoglycerate dehydrogenase (PHGDH) by indole amides abrogates de novo serine synthesis in cancer cells.
Mullarky E; Xu J; Robin AD; Huggins DJ; Jennings A; Noguchi N; Olland A; Lakshminarasimhan D; Miller M; Tomita D; Michino M; Su T; Zhang G; Stamford AW; Meinke PT; Kargman S; Cantley LC
Bioorg Med Chem Lett; 2019 Sep; 29(17):2503-2510. PubMed ID: 31327531
[TBL] [Abstract][Full Text] [Related]
7. Rational Design of Selective Allosteric Inhibitors of PHGDH and Serine Synthesis with Anti-tumor Activity.
Wang Q; Liberti MV; Liu P; Deng X; Liu Y; Locasale JW; Lai L
Cell Chem Biol; 2017 Jan; 24(1):55-65. PubMed ID: 28042046
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of phosphoglycerate dehydrogenase inhibits proliferation and enhances cisplatin sensitivity in cervical adenocarcinoma cells by regulating Bcl-2 and caspase-3.
Jing Z; Heng W; Xia L; Ning W; Yafei Q; Yao Z; Shulan Z
Cancer Biol Ther; 2015; 16(4):541-8. PubMed ID: 25719555
[TBL] [Abstract][Full Text] [Related]
9. 3-Phosphoglycerate dehydrogenase: a potential target for cancer treatment.
Li M; Wu C; Yang Y; Zheng M; Yu S; Wang J; Chen L; Li H
Cell Oncol (Dordr); 2021 Jun; 44(3):541-556. PubMed ID: 33735398
[TBL] [Abstract][Full Text] [Related]
10. Discovery of PHGDH inhibitors by virtual screening and preliminary structure-activity relationship study.
Zhang FM; Yuan L; Shi XW; Feng KR; Lan X; Huang C; Lin GQ; Tian P; Huang M; Tang S; Gao D
Bioorg Chem; 2022 Apr; 121():105705. PubMed ID: 35235889
[TBL] [Abstract][Full Text] [Related]
11. A PHGDH inhibitor reveals coordination of serine synthesis and one-carbon unit fate.
Pacold ME; Brimacombe KR; Chan SH; Rohde JM; Lewis CA; Swier LJ; Possemato R; Chen WW; Sullivan LB; Fiske BP; Cho S; Freinkman E; Birsoy K; Abu-Remaileh M; Shaul YD; Liu CM; Zhou M; Koh MJ; Chung H; Davidson SM; Luengo A; Wang AQ; Xu X; Yasgar A; Liu L; Rai G; Westover KD; Vander Heiden MG; Shen M; Gray NS; Boxer MB; Sabatini DM
Nat Chem Biol; 2016 Jun; 12(6):452-8. PubMed ID: 27110680
[TBL] [Abstract][Full Text] [Related]
12. Phosphoglycerate dehydrogenase promotes proliferation and bortezomib resistance through increasing reduced glutathione synthesis in multiple myeloma.
Wu X; Xia J; Zhang J; Zhu Y; Wu Y; Guo J; Chen S; Lei Q; Meng B; Kuang C; Feng X; He Y; Shen Y; Li X; Qiu L; Li G; Zhou W
Br J Haematol; 2020 Jul; 190(1):52-66. PubMed ID: 32037523
[TBL] [Abstract][Full Text] [Related]
13. Overcoming erlotinib resistance in EGFR mutation-positive lung adenocarcinomas through repression of phosphoglycerate dehydrogenase.
Dong JK; Lei HM; Liang Q; Tang YB; Zhou Y; Wang Y; Zhang S; Li WB; Tong Y; Zhuang G; Zhang L; Chen HZ; Zhu L; Shen Y
Theranostics; 2018; 8(7):1808-1823. PubMed ID: 29556358
[TBL] [Abstract][Full Text] [Related]
14. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer.
Possemato R; Marks KM; Shaul YD; Pacold ME; Kim D; Birsoy K; Sethumadhavan S; Woo HK; Jang HG; Jha AK; Chen WW; Barrett FG; Stransky N; Tsun ZY; Cowley GS; Barretina J; Kalaany NY; Hsu PP; Ottina K; Chan AM; Yuan B; Garraway LA; Root DE; Mino-Kenudson M; Brachtel EF; Driggers EM; Sabatini DM
Nature; 2011 Aug; 476(7360):346-50. PubMed ID: 21760589
[TBL] [Abstract][Full Text] [Related]
15. Inhibiting phosphoglycerate dehydrogenase counteracts chemotherapeutic efficacy against MYCN-amplified neuroblastoma.
Arlt B; Zasada C; Baum K; Wuenschel J; Mastrobuoni G; Lodrini M; Astrahantseff K; Winkler A; Schulte JH; Finkler S; Forbes M; Hundsdoerfer P; Guergen D; Hoffmann J; Wolf J; Eggert A; Kempa S; Deubzer HE
Int J Cancer; 2021 Mar; 148(5):1219-1232. PubMed ID: 33284994
[TBL] [Abstract][Full Text] [Related]
16. Identification of a novel PHGDH covalent inhibitor by chemical proteomics and phenotypic profiling.
Chen C; Zhu T; Liu X; Zhu D; Zhang Y; Wu S; Han C; Zhang H; Luo J; Kong L
Acta Pharm Sin B; 2022 Jan; 12(1):246-261. PubMed ID: 35127383
[TBL] [Abstract][Full Text] [Related]
17. Phosphoglycerate dehydrogenase (PHGDH) inhibitors: a comprehensive review 2015-2020.
Spillier Q; Frédérick R
Expert Opin Ther Pat; 2021 Jul; 31(7):597-608. PubMed ID: 33571419
[No Abstract] [Full Text] [Related]
18. High Phosphoglycerate Dehydrogenase Expression Induces Stemness and Aggressiveness in Thyroid Cancer.
Jeon MJ; You MH; Han JM; Sim S; Yoo HJ; Lee WK; Kim TY; Song DE; Shong YK; Kim WG; Kim WB
Thyroid; 2020 Nov; 30(11):1625-1638. PubMed ID: 32438862
[No Abstract] [Full Text] [Related]
19. Repression of phosphoglycerate dehydrogenase sensitizes triple-negative breast cancer to doxorubicin.
Zhang X; Bai W
Cancer Chemother Pharmacol; 2016 Sep; 78(3):655-9. PubMed ID: 27473325
[TBL] [Abstract][Full Text] [Related]
20. Discovery of novel inhibitors of human phosphoglycerate dehydrogenase by activity-directed combinatorial chemical synthesis strategy.
Zhou X; Tan Y; Gou K; Tao L; Luo Y; Zhou Y; Zuo Z; Sun Q; Luo Y; Zhao Y
Bioorg Chem; 2021 Oct; 115():105159. PubMed ID: 34298241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
